Jianfeng Pharmaceutical ranks among the top 100 Chinese pharmaceutical industries in 2019


Release time:

2020-09-03

  8Month25day,"2019The annual list of China's top 100 pharmaceutical industry "was released in Kunming. Zhejiang Jianfeng Pharmaceutical Company was shortlisted as one of the top 100 pharmaceutical enterprises in China's pharmaceutical industry. The product Berunning (Olopatadine Hydrochloride Eye Drops) was selected as the" Most Growing Product Brand "of China's pharmaceutical industry".

The "Top 100 Pharmaceutical Industry Series List" was evaluated and released by Guangzhou Punctuation Pharmaceutical Information Co., Ltd., a subsidiary of the Southern Institute of Pharmaceutical Economics of the State Drug Administration, and is known as the "Oscar in the Chinese pharmaceutical industry. Southern Institute is the earliest institution in China that specializes in pharmaceutical industry policy and market economy research, pharmaceutical market research, pharmaceutical economic data analysis and research, and pharmaceutical professional media publishing. It is in the field of market information value-added services and media communication and marketing services in China's pharmaceutical and health industry., The field of professional quality improvement has extremely extensive influence. The "Top 100 Pharmaceutical Industry" is comprehensively evaluated by the company's annual pharmaceutical industry sales revenue, total profit and R & D investment results.

On the same day, the "most growing product brand" of Chinese medicine selected by the Southern Institute's media "Pharmaceutical Economic News" was released simultaneously. Spike Pharmaceuticals product Berunning (Olopatadine Hydrochloride Eye Drops) was selected.